Invention Grant
US08440698B2 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
有权
3-（4 - （（1H-咪唑-1-基）甲基）苯基）-5-芳基-1,2,4-恶二唑衍生物作为鞘氨醇-1磷酸受体调节剂
- Patent Title: 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
- Patent Title (中): 3-（4 - （（1H-咪唑-1-基）甲基）苯基）-5-芳基-1,2,4-恶二唑衍生物作为鞘氨醇-1磷酸受体调节剂
-
Application No.: US13567654Application Date: 2012-08-06
-
Publication No.: US08440698B2Publication Date: 2013-05-14
- Inventor: Janet A. Takeuchi , Ken Chow , Ling Li
- Applicant: Janet A. Takeuchi , Ken Chow , Ling Li
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agency: Allergan, Inc.
- Agent John E. Wurst; Doina G. Ene
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61K31/454
Abstract:
Substituted 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-phenyl-1,2,4-oxadiazole derivatives which are useful as sphingosine-1-phosphate modulators and useful for treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.
Public/Granted literature
Information query
